NEXUS Biosystems and Bruker Renew Worldwide Distribution Partnership
News May 17, 2006
NEXUS Biosystems, Inc. has renewed its worldwide marketing agreement with Bruker AXS Inc. for Bruker AXS Inc. to continue to globally market, sell, and support the NEXUS Crystal Farm line of products for protein crystallography research.
NEXUS Biosystems' Crystal Farm is an expanding line of automated instrumentation products focused on addressing the needs of protein crystallization. At the core of the Crystal Farm is a high resolution imaging system that can quickly and consistently image hanging, sitting, or micro-batch drops in virtually all plate types.
System control and image analysis can be directly or remotely accessed via Crystal Navigator, Crystal Farm's scalable web based software. The Crystal Farm is available in three different models, the CF-150, CF-400, and CF-5000, each addressing different research needs, from academic to high throughput drug discovery.
"The Crystal Farm product line is a world class family of products in use at many pharmaceutical, academic, research, and biotech crystallography organizations around the world. We are very pleased to be continuing our distribution relationship with Bruker AXS, the leading provider of instrumentation for the crystallography market," stated NEXUS Biosystems' CEO, John Lillig. "We feel that Bruker AXS' industry knowledge, experience, and global resources make them the ideal choice as our distribution partner."
Roger Durst, Ph.D., Chief Technology Officer of Bruker AXS added: "We are pleased to renew our very successful agreement with NEXUS to distribute the market-leading Crystal Farm product line. The Crystal Farm is an extremely powerful tool for protein crystallization and it is an important part of Bruker AXS' comprehensive portfolio of instrumentation for macromolecular crystallography."
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018